Effects of DDAVP, a synthetic analogue of vasopressin, in patients with cranial diabetes insipidus.
D000328:Adult; D002747:Chlorpropamide / Q000627:therapeutic use; D002752:Chlorthalidone / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D014667:Vasopressins / Q000008:administration & dosage / Q000627:therapeutic use*
D014667:Vasopressins; D002752:Chlorthalidone; D002747:Chlorpropamide